Peripheral Stent
Peripheral artery disease
ApprovedActive
Key Facts
About Advanced Biomed
Advanced Biomed is a commercial-stage medical device company headquartered in Taipei, Taiwan. It specializes in stents and catheters for cardiovascular and interventional procedures. Little public information is available about its pipeline, funding, or leadership, but it appears to operate in the competitive interventional cardiology market with a focus on accessible, cost-effective devices for Asian and emerging markets.
View full company profileTherapeutic Areas
Other Peripheral artery disease Drugs
| Drug | Company | Phase |
|---|---|---|
| Peripheral Artery Disease Program | Elixir Medical | Pre-clinical |
| Aperta NSE™ PTA | Nipro Medical | Commercial |
| JTV-263 | Akros Pharma | Phase1 |
| Luminor DCB | iVascularU | Post-Market |
| iVolution pro Stent | iVascularU | Post-Market |
| FGF-1 | Zhittya Genesis Medicine | Phase 2 |
| ChampioNIR | Medinol | Investigational |
| Ranger DCB | Boston Scientific | Pivotal Trial |